Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | 204,000 | 382,000 | 912,000 | 314,000 | 233,000 |
| Other Working Capital | -133,000 | -202,000 | -2,088,000 | -135,000 | 241,000 |
| Other Operating Activity | 1,640,000 | 1,067,000 | 3,090,000 | -467,000 | 1,263,000 |
| Operating Cash Flow | $1,711,000 | $1,247,000 | $1,914,000 | $-288,000 | $1,737,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -250,000 | -231,000 | -372,000 | -222,000 | -231,000 |
| Net Acquisitions | -204,000 | -6,000 | -31,000 | -2,249,000 | -217,000 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | 2,000 |
| Sale Of Investment | 11,000 | 4,000 | 145,000 | N/A | N/A |
| Purchase Sale Intangibles | -53,000 | -82,000 | 24,000 | -52,000 | 312,000 |
| Other Investing Activity | 120,000 | 17,000 | 167,000 | 176,000 | 453,000 |
| Investing Cash Flow | $-480,000 | $-298,000 | $-236,000 | $-2,408,000 | $-117,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -622,000 | -1,749,000 | -704,000 | 507,000 | -609,000 |
| Debt Issued | 12,000 | 1,901,000 | 1,377,000 | 0 | N/A |
| Common Stock Issued | 306,000 | 120,000 | 97,000 | 90,000 | 109,000 |
| Common Stock Repurchased | -320,000 | -88,000 | -653,000 | -777,000 | -843,000 |
| Dividend Paid | -1,068,000 | -870,000 | -830,000 | -846,000 | -1,291,000 |
| Other Financing Activity | -406,000 | -769,000 | -304,000 | -186,000 | 2,744,000 |
| Financing Cash Flow | $-2,098,000 | $-1,455,000 | $-1,017,000 | $-1,212,000 | $110,000 |
| Exchange Rate Effect | -67,000 | 128,000 | -35,000 | -20,000 | -11,000 |
| Beginning Cash Position | 3,528,000 | 3,906,000 | 3,281,000 | 7,209,000 | 5,490,000 |
| End Cash Position | 2,594,000 | 3,528,000 | 3,906,000 | 3,281,000 | 7,209,000 |
| Net Cash Flow | $-867,000 | $-506,000 | $661,000 | $-3,908,000 | $1,730,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,711,000 | 1,247,000 | 1,914,000 | -288,000 | 1,737,000 |
| Capital Expenditure | -425,000 | -317,000 | -523,000 | -383,000 | -359,000 |
| Free Cash Flow | 1,286,000 | 930,000 | 1,391,000 | -671,000 | 1,378,000 |